Clinical Trials Logo
  1. Home
  2. Skin Cancer
  3. NCT04064424
  4. Details
NCT04064424 Clinical Trial

Cancer Prevention & Online Technologies

Skin Cancer Clinical Trial

Official title:
Cancer Prevention & Online Technologies

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT04064424
Other study ID # IRB-50303
Secondary ID IRB-50303SKIN004
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 2024
Est. completion date November 2024

Study information
Verified date January 2024
Source Stanford University
Contact Lily Morrison
Phone 650-723-6109
Email Lily.morrison@stanford.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The overall goal of this research is to develop interventions that leverage online technology (e.g. ads, social media) to reduce individuals' skin-cancer-related risk behaviors and ultimately to reduce skin cancer incidence.

Description:

This research includes three phases: 1. To better understand the motivators and inhibitors of skin cancer risk behaviors in various populations including use of indoor tanning and outdoor sun exposure; 2. To develop content messages and images related to skin cancer risk that are resonant with various populations; 3. To test the relative effectiveness of these messages in reducing likelihood of or actual skin cancer risk behaviors in various populations.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 720000
Est. completion date November 2024
Est. primary completion date November 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Facebook user between the age of 18 and 65 - Self-identifies as male - Profile indicates interest in at least one of the following: LGBT community, LGBT culture, LGBT social movements, Rainbow flag, Gay pride, GAY-friendly, homosexuality Exclusion Criteria: - Failure to meet inclusion criteria

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Prevention video advertisement
Skin Cancer Prevention videos
• Prevention images for advertisement
Skin Cancer Prevention images
• No Advertisement
No skin cancer prevention videos or images were advertised.

Locations
Country Name City State
n/a

Sponsors (2)
Lead Sponsor Collaborator
Stanford University National Cancer Institute (NCI)

Outcome
Type Measure Description Time frame Safety issue
Primary Measure intent to tan Intent to tan will be measured by our follow-up survey question. Rates of each response will be compared between experimental groups. 4 weeks
Secondary Measure awareness of indoor tanning risk Awareness of indoor tanning risk will be measured by our follow-up survey question. Rates of each response will be compared between experimental groups. 4 weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02721459 - XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma Phase 1
Completed NCT03740815 - Feasibility of Serratus Plane Block Associated With Sedation in Axillary Dissection N/A
Recruiting NCT05779423 - Cryoablation+Ipilimumab+Nivolumab in Melanoma Phase 2
Terminated NCT01468818 - Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma Phase 2
Completed NCT01820234 - Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event N/A
Completed NCT00535769 - Evaluation of Adherence to Topical Agents: Applying Communication Technology to Improve Sunscreen Use Phase 0
Completed NCT00526032 - Melanoma Detection by Oblique-Incidence Optical Spectroscopy N/A
Completed NCT00588341 - Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection Phase 2
Active, not recruiting NCT01447199 - The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
Enrolling by invitation NCT04758988 - AI Augmented Training for Skin Specialists N/A
Not yet recruiting NCT04534868 - Patient Acceptance And Satisfaction of Teledermoscopy In General Practice In a Belgian Rural Area N/A
Recruiting NCT04138342 - Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer Phase 1
Completed NCT03673917 - Cosmetology Students and Skin Cancer N/A
Recruiting NCT04341064 - Sun-safe Habits Intervention and Education Phase 3
Completed NCT04206995 - Cancer Sensing: Evaluation of Odour Sampling Techniques
Recruiting NCT05574101 - A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer Phase 2
Not yet recruiting NCT05860881 - Topical Sirolimus in Chemoprevention of Facial Squamous Cell Carcinomas in Solid Organ Transplant Recipients (SiroSkin) Phase 3
Completed NCT05146622 - Virtual Sun Safe Workplaces Ph I
Recruiting NCT05068310 - Applicability of a Cellular Resolution Full-field OCT Image System for Pigmented and Non-pigmented Skin Tumors
Recruiting NCT03889899 - Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia. N/A